The Many Faces of Aβ: Structures and Activity
The DOI matches its Crossref record.
Abstract
Although converging lines of evidence suggest a central role for amyloid ß-protein (Aß) in the etiology of Alzheimers disease (AD), the active form(s) of Aβ that leads to altered neuronal function and death have not been definitively identified. Indeed, until recently, efforts at understanding Aβ aggregation and toxicity focused primarily on fibrillar forms of Aβ akin to those detected in senile plaques. But plaque density and severity of dementia correlate weakly and recent studies report more robust correlations between the levels of soluble Aβ and the extent of synaptic loss and severity of cognitive impairment. Moreover, the identification of pre-fibrillar intermediates in vitro and the detection of SDS-stable oligomers of Aβ in human brain and CSF and in the medium of cells expressing human Aβ demonstrate the existence of soluble, non-fibrillar Aβ assemblies. Because great effort is currently being expended on the development of anti-amyloid therapeutics, it is crucial that remaining concerns about a causative role for Aß in AD be rigorously addressed. Here we review evidence that Aβ toxicity is likely to be mediated by multiple different Aβ assembly forms and discuss possible therapeutic strategies designed to remove or prevent the formation of soluble toxic assemblies. Keywords: Alzheimer, Amyloids, pre-fibrillar
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
“…aggregation of synthetic Ab in vitro and can inhibit amyloid plaque formation in APP transgenic mice (Gervais et al. 2006) Although many inhibitors of in vitro Ab aggregation have been identified (for a review see, Walsh et al. 2003), molecules capable of disrupting pre-formed oligomers (Fig.”
BackgroundSelf-citationNatural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Self-citationSoluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Self-citationWalsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., Agnaf, O. E., Hartley, D. M., & Selkoe, D. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4391-04.2005 · Cited by 286
Self-citation
Metadata
- Authors
- Walsh, D., Hartley, D., & Selkoe, D.
- Venue
- Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-12-01
- Volume
- 3
- Issue
- 4
- Pages
- 277-291
- ISSN
- 1568-0134 (ISSN-L)
- OpenAlex
- W2323560519
- Cited by
- 21
- References
- 0
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Many Faces of Aβ: Structures and Activity. https://app.cochat.ai/papers/10.2174/1568013033483311
- The paper
- Walsh, D., Hartley, D., & Selkoe, D. (2003). The Many Faces of Aβ: Structures and Activity. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. https://doi.org/10.2174/1568013033483311
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.